A clinical trial to study the effect of Patra pinda sweda along with shoulder joint mobilization in avabahuk.

A Randomised Controlled Clinical Trial To Study The Adjuvant Effect of Patra Pinda Sweda Along With Shoulder Joint Mobilization in Avabahuka with special reference to Frozen shoulder. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090971

Enrollment

Registered

2025-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having classical signs and symptoms of Avabahuka like pain, stiffness and Restricted Range of motion of shoulder joint. 2. Gender- patients of all genders 3. Age-between years 35-70yrs 4. Economic status-All 5. 2nd and 3rd stage of Frozen shoulder i.e. 4 month to 42 months.

Exclusion criteria

Exclusion criteria: 1.. Patients with other joint disorder which does not relates to Avabahuka will be excluded. 2. patients with traumatic, infective, neoplastic joint and cardiovascular disease. 3. Patients having congenital structural disorder will be excluded. 4. Patient having any type of arthritis, developed a painful stiff shoulder after a severe trauma to upper extremity, Previous fractures or dislocations of the shoulder complex, Rotator cuff tendinitis or tear, Previous intra-articular injection or surgical release and Complex regional pain syndrome Will be excluded from the study. 5. patients with 1st stage of Frozen shoulder. 6. Patients with diabetes mellitus.

Design outcomes

Primary

Measure	Time frame
To assess the effect of Patrapinda sweda along with shoulder joint mobilization for 7 days in sign and symptoms of avabahuk by the comparison of the score of clinical evaluationTimepoint: 14 days	—

Secondary

Measure	Time frame
Whether the trial group stands in comparison to control group in reduction of signs and symptoms of Avabahuka.Timepoint: 18 months	—

Countries

India

Contacts

Public ContactDr Supriya Vitthal Temkar

SMBT college and hospital, Dhamangaon , Igatpuri,Nashik - 422403, Maharashtra , India.

vdpramod31@gmail.com9604633832

Outcome results